Cargando…

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol

Myo-Inositol and D-chiro-inositol (MI-DCI) are used in the treatment of polycystic Ovary syndrome (PCOS) due to their insulin-sensitizing actions. Therefore, it is of interest to evaluate the treatment patterns, clinical effectiveness and safety of MI-DCI combination in anagement of PCOS in Indian w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vyas, Lila, Raiturker, Anagha Pai, Sud, Shilpi, Goyyal, Poonam, Abhyankar, Mahesh, Revankar, Santosh, Walia, Silki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649498/ https://www.ncbi.nlm.nih.gov/pubmed/36420435 http://dx.doi.org/10.6026/97320630018103

Ejemplares similares

Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review
por: Bizzarri, Mariano, et al.
Publicado: (2023)

Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition
por: Tortolini, Cristina, et al.
Publicado: (2023)

The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
por: Pintaudi, Basilio, et al.
Publicado: (2016)

PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
por: Monastra, Giovanni, et al.
Publicado: (2021)

CONCERN: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2012)

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
por: Troisi, Jacopo, et al.
Publicado: (2019)

Determination of Urinary Myo-/Chiro-Inositol Ratios from Korean Diabetes Patients
por: Jung, Tae-Sik, et al.
Publicado: (2005)

Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)

Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)

The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
por: Kamenov, Zdravko, et al.
Publicado: (2023)

A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
por: Benelli, Elena, et al.
Publicado: (2016)

Urinary Chiro- and Myo-Inositol Levels as a Biological Marker for Type 2 Diabetes Mellitus
por: Hong, Jun Hwa, et al.
Publicado: (2012)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

d-chiro-Inositol Ribophostin: A Highly Potent Agonist of d-myo-Inositol 1,4,5-Trisphosphate Receptors: Synthesis and Biological Activities
por: Mills, Stephen J., et al.
Publicado: (2020)

D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2)
por: Monastra, Giovanni, et al.
Publicado: (2023)

Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
por: Merviel, Philippe, et al.
Publicado: (2021)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review
por: Davinelli, Sergio, et al.
Publicado: (2020)

Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
por: Montanino Oliva, Mario, et al.
Publicado: (2018)

D-Chiro-Inositol Regulates Insulin Signaling in Human Adipocytes
por: Montt-Guevara, Maria Magdalena, et al.
Publicado: (2021)

The effect of D-chiro-inositol on renal protection in diabetic mice
por: Fan, Chunxue, et al.
Publicado: (2022)

D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study
por: Porcaro, Giuseppina, et al.
Publicado: (2023)

Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate
por: Bizzarri, Mariano, et al.
Publicado: (2016)

Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case–Control Analysis
por: Dellino, Miriam, et al.
Publicado: (2022)

The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
por: Yang, Hyun, et al.
Publicado: (2022)

New Insights into the Activities of D-Chiro-Inositol: A Narrative Review
por: Gambioli, Riccardo, et al.
Publicado: (2021)

Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside
por: Nordio, Maurizio, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
por: Sortino, Maria A., et al.
Publicado: (2017)

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome
por: Cheang, Kai I., et al.
Publicado: (2016)

2-Benzyl-myo-inositol monohydrate
por: Fröhlich, Richard F. G., et al.
Publicado: (2009)

D-Chiro-Inositol Improves Sperm Mitochondrial Membrane Potential: In Vitro Evidence
por: Condorelli, Rosita A., et al.
Publicado: (2020)

Myo-Inositol’s Role in Assisted Reproductive Technology: Evidence for Improving the Quality of Oocytes and Embryos in Patients With Polycystic Ovary Syndrome
por: Gupta, Deepti, et al.
Publicado: (2020)

High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries
por: Bevilacqua, Arturo, et al.
Publicado: (2021)

Myo-inositol oxygenase is important for the removal of excess myo-inositol from syncytia induced by Heterodera schachtii in Arabidopsis roots
por: Siddique, Shahid, et al.
Publicado: (2014)

Harnessing (13)C-labeled myo-inositol to interrogate inositol phosphate messengers by NMR
por: Harmel, Robert K., et al.
Publicado: (2019)

Inhibited inositol monophosphatase and decreased myo‐inositol concentration improve wasting in skeletal muscles
por: Lee, Ji‐Hyung, et al.
Publicado: (2020)

Inositol in Disease and Development: Roles of Catabolism via myo-Inositol Oxygenase in Drosophila melanogaster
por: Contreras, Altagracia, et al.
Publicado: (2023)

Valproate regulates inositol synthesis by reducing expression of myo-inositol-3-phosphate synthase
por: Case, Kendall C., et al.
Publicado: (2023)

Myo-Inositol in the Treatment of Teenagers Affected by PCOS
por: Pkhaladze, Lali, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rtg38u3tp70q9jhg1rh3ho2e7r